ML Pastor, CM Laffont, L Gladieff, A Schmitt… - Pharmaceutical …, 2013 - Springer
Purpose Granulocyte colony-stimulating factor (G-CSF) is often used in cancer patients receiving cytotoxic drugs to prevent or reduce high grade neutropenia. We propose a …
Les travaux de cette thèse s' appuient sur les résultats d'une étude de cohorte ayant pour objectif principal de définir le schéma optimal d'administration prophylactique des facteurs …
Cancer is the second leading cause of death in the US and Europe (World Health Organization) and even though there has been a profound improvement of the treatment of …
T Takanohashi, H Arisaka, K Ubukata… - European journal of …, 2012 - Springer
Nateglinide and mitiglinide are immediate short-acting insulinotropic agents. Both are administered preprandially to control postprandial hyperglycemia. Glinide drugs are …
Purpose: Neutropenia is a common and serious side-effect of chemotherapeutics. The main regulating factor for neutrophils (ANC) is granulocyte colony stimulating factor (G-CSF) …